Recruiting A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors NCT06789172 Conditions Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more Locations Precision NextGen Oncology and Research Center — Beverly Hills, California, United States Sarcoma Oncology Center — Santa Monica, California, United States MD Anderson Cancer Center — Houston, Texas, United States Chris O'Brien Lifehouse — Sydney, New South Wales, Australia View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. NCT07173972 Conditions Dermatofibrosarcoma, Fibrosarcoma, Histiocytoma, +21 more Locations Haukeland University Hospital — Bergen, Norway Oslo University Hospital — Oslo, Norway View Trial Details
Recruiting Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344 Conditions Dermatofibrosarcoma, Fibrosarcoma, Histiocytoma, +19 more Locations Haukeland University Hospital — Bergen, Norway Oslo University Hospital — Oslo, Norway University Hospital of North Norway — Tromsø, Norway St. Olavs University Hospital — Trondheim, Norway View Trial Details
